Vaccines

01 Feb 2011 Bavarian Nordic Completes Smallpox Vaccine Phase 2 Trial in Vulnerable Population
01 Feb 2011 Circassia's ToleroMune(R) T-cell Vaccine Achieves Significant Reduction in Allergy Symptoms in Key Phase II Clinical Study
31 Jan 2011 Sinovac Biotech Files Clinical Trial Applications with SFDA for its Proprietary Pneumococcal Polysaccharides Vaccines (PPV)
31 Jan 2011 FDA approves the Novartis quadrivalent meningococcal conjugate vaccine, Menveo, for use in children from 2 years of age
31 Jan 2011 University of Southampton and Inovio Pharmaceuticals Initiate Phase 2 Clinical Study to Evaluate Leukemia DNA Vaccine Using Electroporation Delivery Technology
25 Jan 2011 BioSante Announces FDA Orphan Drug Designation for its Melanoma Cancer Vaccine
25 Jan 2011 Generex to Increase Patient Enrollment of its Phase II Breast Cancer Vaccine Study
25 Jan 2011 GenVec and U.S. Naval Medical Research Center to Collaborate on Vaccine for Dengue Fever
24 Jan 2011 Northwest Biotherapeutics Resuming Enrollment In Promising 240-Patient Clinical Trial of DCVax for Brain Cancer
21 Jan 2011 Joint development of therapeutic cancer vaccine WT4869
14 Jan 2011 Independent Data Safety Monitoring Board Gives “Go-Ahead” to Complete Dosing in First Leg of Advaxis’ Phase II Cervical Dysplasia Trial
13 Jan 2011 Recipharm AB Announces Successful Pre-Clinical Tuberculosis Vaccine Results using its Oral Vaccine Delivery Platform
12 Jan 2011 Preclinical Efficacy of Inovio Pharmaceuticals’ Chikungunya DNA Vaccine Featured in PLoS Neglected Tropical Diseases
11 Jan 2011 Publication Highlights Allovectin-7(R) Phase 2 Safety and Efficacy Results in Melanoma
10 Jan 2011 Inovio Pharmaceuticals’ Novel DNA Vaccine for Clade C HIV Achieves Immune Responses and Protection in Non-Human Primates
06 Jan 2011 Generex and RXi Pharmaceuticals Announce Positive Research Data Using RNAi Technology in the Development of Therapeutic Vaccines for Cancer
05 Jan 2011 Medicago announces Publication of its Phase I Study with its Pandemic H5N1 Influenza Virus-Like Particle (VLP) Vaccine Candidate
05 Jan 2011 Profectus BioSciences Announces Initiation of Clinical Trial of IL-12 Enhanced Therapeutic HIV DNA Vaccine Delivered Using Electroporation
05 Jan 2011 Opexa Completes Successful Meetings with FDA to Pursue Phase 3 Clinical Study for Tovaxin in Multiple Sclerosis
04 Jan 2011 ImmunoCellular Therapeutics Receives FDA Approval to Commence Phase II Trial of ICT-107
04 Jan 2011 NOVAVAX Launches Phase I Clinical Trial to Evaluate its Novel Vaccine Against Respiratory Syncytial Virus (RSV)
28 Dec 2010 Sinovac Receives SFDA Approval to Commence Clinical Trials for Inactivated Enterovirus Type 71 Vaccine
28 Dec 2010 Emergent BioSolutions Starts Phase I Clinical Trial for Third Generation Anthrax Vaccine
23 Dec 2010 Dynavax Reports Phase 1B Safety and Immunogenicity Results for Hepatitis B Therapy Candidate
23 Dec 2010 US FDA Approves New Indication for Merck's HPV Vaccine, GARDASIL

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top